Department of Clinical Medicine, University of La Sapienza, Rome, Italy.
Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S24-7. Epub 2011 Sep 27.
Given the pathological similarities between Behçet's disease (BD), Familial Mediterranean fever (FMF), TNF receptor-associated periodic syndrome (TRAPS) and Crohn's disease (CD) we evaluated the frequency of mutations and polymorphisms in MEFV, TNFRSF1A and CARD15 in Israeli BD patients of either Jewish or Arab descent.
Fifty-four BD patients (11 Jews and 43 Arabs), evaluated with respect to the entire spectrum of BD disease manifestations, were granted a systemic severity score for BD. An association between BD manifestations and MEFV, TNFRSF1A and CARD15 variants was analysed.
Twelve patients (20.7%) displayed a single MEFV mutation and four patients (7.4%) had two mutated FMF alleles. Two patients (3.8%) carried a CARD15 variation and none carried a TNFRSF1A polymorphism. The frequency and distribution of mutated alleles between patients and controls was comparable (p=0.27). No statistically significant differences between carriers and non-carriers with respect to disease manifestations and severity score were calculated. Arab patients were diagnosed earlier than Jewish patients (25.8±11.6 and 37.2±10.7, respectively, p=0.06).
The overall MEFV high carrier frequency in our cohort of BD patients seems to be attributed to their Mediterranean extraction rather than related to BD. The propensity of Arab patients (79.6%) in a cohort of BD patients from northern Israel is highlighted in face of their proportion (20%) in the general population lending further support to arguments that favour a genetic component for BD.
鉴于白塞病(BD)、家族性地中海热(FMF)、肿瘤坏死因子受体相关周期性综合征(TRAPS)和克罗恩病(CD)之间存在病理相似性,我们评估了 MEFV、TNFRSF1A 和 CARD15 中的突变和多态性在以色列犹太裔或阿拉伯裔 BD 患者中的频率。
对 54 名 BD 患者(11 名犹太人和 43 名阿拉伯人)进行了评估,评估了 BD 疾病表现的整个谱,为 BD 患者授予了系统性严重程度评分。分析了 BD 表现与 MEFV、TNFRSF1A 和 CARD15 变体之间的关联。
12 名患者(20.7%)携带单个 MEFV 突变,4 名患者(7.4%)携带两个突变的 FMF 等位基因。2 名患者(3.8%)携带 CARD15 变异,无人携带 TNFRSF1A 多态性。患者和对照组之间突变等位基因的频率和分布无差异(p=0.27)。未计算出携带和非携带者在疾病表现和严重程度评分方面的统计学差异。阿拉伯患者的诊断时间早于犹太患者(分别为 25.8±11.6 和 37.2±10.7,p=0.06)。
我们的 BD 患者队列中 MEFV 高携带者的总体高频率似乎归因于他们的地中海血统,而不是与 BD 相关。在来自以色列北部的 BD 患者队列中,阿拉伯患者(79.6%)的倾向突显出来,而他们在总人口中的比例(20%)进一步支持了支持 BD 具有遗传成分的论点。